Edward J. Dulac III
Chief Financial Officer
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Fate Therapeutics Inc (FATE) | Chief Financial Officer | $475,000 | $2,824,498 |
| 2022 | Fate Therapeutics Inc (FATE) | Chief Financial Officer | $455,000 | $3,157,751 |
| 2021 | Fate Therapeutics Inc (FATE) | Chief Financial Officer | $420,000 | $6,384,051 |
| 2020 | Fate Therapeutics Inc (FATE) | Chief Financial Officer | $142,500 | $5,683,579 |
Executive changes
Earnings-call appearances
No earnings-call appearances recorded yet.